Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
TORONTO and ATHENS, Greece, July 22, 2019 (GLOBE NEWSWIRE) -- Global Cannabis Corp. (“GCC” or the “Company”) and its partner SLANG Worldwide Inc. (CNSX: SLNG), (Frankfurt: 84S), ("SLANG") are...
TORONTO, July 18, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal...
TORONTO, June 11, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries"), a leading Latin American licensed producer of medicinal cannabis and...
RNS Number:9452S Slingsby(H.C.)Plc 05 December 2003 HC SLINGSBY PLC HOLDING IN THE COMPANY The Company has been notified today that in accordance with section 198 of the...
RNS Number:7358R Slingsby(H.C.)Plc 05 November 2003 HC SLINGSBY PLC ("THE COMPANY") Notifiable Interest and Directors' Shareholdings The Company has been notified today that, in...
RNS Number:2025Q Slingsby(H.C.)Plc 26 September 2003 H C Slingsby plc Report for the half year ended 30 June 2003 Statement by the Chairman Although it is disappointing to report...
RNS Number:4061K Slingsby(H.C.)Plc 25 April 2003 H C SLINGSBY PLC Preliminary announcement for the year to 31 December 2002 Statement by the Chairman It is satisfying to...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.005 | 0.005 | 0.005 | 1000 | 0.005 | CS |
| 4 | -0.005 | -50 | 0.01 | 0.01 | 0.005 | 113210 | 0.00634499 | CS |
| 12 | -0.005 | -50 | 0.01 | 0.015 | 0.005 | 74367 | 0.00712879 | CS |
| 26 | -0.035 | -87.5 | 0.04 | 0.04 | 0.005 | 82429 | 0.01308736 | CS |
| 52 | -0.03 | -85.7142857143 | 0.035 | 0.045 | 0.005 | 86220 | 0.02353457 | CS |
| 156 | -0.12 | -96 | 0.125 | 0.45 | 0.005 | 91418 | 0.05480608 | CS |
| 260 | -0.495 | -99 | 0.5 | 0.75 | 0.005 | 250208 | 0.22199857 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
